Sign In
Buy ENVB
$1.98
-0.240 (-10.81%)
At Close: Jun 03, 2026
Enveric Biosciences to Present at the Gravitas Securities Inc. 6th Annual Growth Conference
07:33am, Wednesday, 22'nd Feb 2023
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics fo
The 7 Most Promising Psychedelic Stocks to Buy in February
02:30pm, Sunday, 05'th Feb 2023
Psychedelic stocks have seen remarkable progress in recent years, evolving from a fad to mainstream medicine. Several pharmaceutical companies are now investigating their potential therapeutic value.
Enveric Biosciences to Present at the BIO CEO & Investor Conference
07:33am, Wednesday, 01'st Feb 2023
CAMBRIDGE, Mass.--( BUSINESS WIRE )--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics
CAMBRIDGE, Mass.--( BUSINESS WIRE )--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics
Enveric Biosciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022
07:30am, Wednesday, 31'st Aug 2022
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a neuroscience-focused biotechnology company developing next-generation, psychedelic-i
7 Psychedelics Stocks to Buy for a Big Drug Boom
03:02pm, Tuesday, 30'th Aug 2022
Psychedelics stocks are becoming increasingly mainstream, in part due to changing social attitudes. Psychedelic drugs “are a loosely grouped class of drugs that are able to induce altered thoughts a
7 Short-Squeeze Stocks to Put on Your Must-Watch List
04:28pm, Tuesday, 16'th Aug 2022
The beaten-down stock market has created an opportunity for contrarian investors in short-squeeze stocks. Essentially, bearish traders must borrow the underlying securities which they are pessimistic
Enveric Biosciences to Participate in Upcoming Conferences in June 2022
07:30am, Wednesday, 08'th Jun 2022
NAPLES, Fla. , June 8, 2022 /PRNewswire/ - Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a neuroscience-focused biotechnology company developing next-generation, psychedelic
Enveric Biosciences to Participate in Upcoming Investor Conferences in April 2022
07:30am, Wednesday, 06'th Apr 2022
NAPLES, Fla. , April 6, 2022 /PRNewswire/ - Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a neuroscience-focused biotechnology company developing next-generation, psychedel
Enveric Biosciences touts the publication of four patent applications for psychedelic-inspired drug candidates
08:57am, Tuesday, 15'th Mar 2022
Enveric Biosciences (NASDAQ:ENVB) Inc announced that the company's first four Patent Cooperation Treaty (PCT) applications for the tryptamine family of novel molecules have been published by the World
Enveric Biosciences to Participate in Upcoming Investor Conferences in March 2022
12:30pm, Thursday, 03'rd Mar 2022 PR Newswire
NAPLES, Fla., March 3, 2022 /PRNewswire/ - Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a cutting-edge neuroscience company developing next-generation, psychedelic-inspired mental health medicines, today announced that Dr. Joseph Tucker, Chief Executive Officer of…
Thinking about buying stock in Farmmi, Camber Energy, Kaival Brands Innovations, Enveric Biosciences, or Petroleo Brasileiro?
04:00pm, Tuesday, 01'st Mar 2022 Benzinga
NEW YORK , March 1, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FAMI, CEI, KAVL, ENVB, and PBR. … Full story available on Benzinga.com
Enveric Biosciences Files Portfolio of Patent Applications for Tryptamine-Based Molecules
01:19pm, Tuesday, 01'st Mar 2022 InvestorsHub
Enveric Biosciences Files Portfolio of Patent Applications for Tryptamine-Based MoleculesRobust Portfolio of Psychedelic-Inspired Molecules Positions Enveric to Achieve Global Patent Protection to potentially Cover Millions of Novel Pharmaceutical CandidatesNAPLES, Fla., March 1, 2022 -- InvestorsHub NewsWire -- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a neuroscience-focused pharmaceutical company developing next-generation, psychedelic-inspired mental health medicines, ...
Enveric Biosciences files portfolio of patent applications for tryptamine derivatives
09:12am, Tuesday, 01'st Mar 2022
Enveric Biosciences (NASDAQ:ENVB) announced that it has filed its tenth Patent Cooperation Treaty (PCT) application directed to tryptamine-based derivative molecule, completing the company's broad ser
The Behavior Of Enveric Biosciences Inc. (ENVB) Stock Is Not As Predictable As You Think
07:00pm, Friday, 25'th Feb 2022 Stocks Register
Enveric Biosciences Inc. (NASDAQ:ENVB) at last check was buoying at $0.29 on Friday, February 25, with a rise of 8.49% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.27 with its price kept floating in the range of $0.243 and $0.27 … The Behavior Of Enveric Biosciences Inc. (ENVB) Stock Is Not As Predictable As You Think Read More »
